niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
Published 7 years ago • 401 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
9:25
results from the engot-ov16/nova trial: efficacy and safety of niraparib in ovarian cancer
-
2:26
trial design of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
1:14
next steps for niraparib for ovarian cancer following on from the engot-ov16/nova trial
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
5:13
treating ovarian cancer with niraparib: the nova trial
-
3:23
niraparib significantly improves outcomes for ovarian cancer patients
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
2:17
combination therapy to treat ovarian cancer: promising results from the ananova trial
-
1:47
dr. matulonis on the nova trial of niraparib maintenance therapy in ovarian cancer
-
1:48
niraparib maintenance therapy in ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
2:11
design of the nova trial for ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
6:25
niraparib maintenance therapy for ovarian cancer
-
1:45
comment: niraparib for ovarian cancer